SCHEMBL19212256

SCHEMBL19212256

O=C(O)N1CCN(c2ncc(Br)cc2Cl)CC1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
MEN1 O00255 3/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
P2RY12 Q9H244 6/20 0.45
ABL1 P00519 3/20 0.42
BCR P11274 3/20 0.42
LMNA P02545 3/20 0.41
OPRK1 P41145 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14735155 0.85 PHGDH (0.50) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL20524606 0.82 OPRK1 (0.41) SMN1; SMN2ALDH1A1MAPTLMNAOPRK1
SCHEMBL27741480 0.82 SMN1; SMN2 (0.46) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL18837988 0.80 MEN1 (0.53) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL3075186 0.80 CNR2 (0.47) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL27927939 0.80 KMT2A (0.47) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL27927936 0.79 ABL1 (0.44) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL29631786 0.79 HSD11B1 (0.46) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL4098052 0.79 KMT2A (0.44) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL1432330 0.79 SMN1; SMN2 (0.72) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed